Biophytis SA (NASDAQ:BPTS) Short Interest Down 97.7% in December

Biophytis SA (NASDAQ:BPTS) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 300 shares, a decrease of 97.7% from the December 15th total of 13,300 shares. Based on an average daily trading volume, of 4,200 shares, the short-interest ratio is presently 0.1 days.

BPTS stock opened at $4.70 on Friday. The business’s fifty day simple moving average is $5.36 and its two-hundred day simple moving average is $7.27. Biophytis has a twelve month low of $4.61 and a twelve month high of $18.50.

Separately, HC Wainwright restated a “buy” rating on shares of Biophytis in a report on Monday, October 25th.

About Biophytis

Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases.

Recommended Story: What is a Lock-Up Period?

Receive News & Ratings for Biophytis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biophytis and related companies with MarketBeat.com's FREE daily email newsletter.